Objective: HIV-associated nephropathy (HIVAN) is the most common cause of endstage renal disease in persons with HIV/AIDS and is characterized by focal glomerulosclerosis and dysregulated renal tubular epithelial cell (RTEC) proliferation and apoptosis. HIV-1 viral protein r (Vpr) has been implicated in HIV-induced RTEC apoptosis but the mechanisms of Vpr-induced RTEC apoptosis are unknown. The aim of this study was therefore to determine the mechanisms of Vpr-induced apoptosis in RTEC.
Introduction
HIV-associated nephropathy (HIVAN) is the most common cause of end-stage renal disease in HIVseropositive patients and results from direct infection of renal epithelial cells [1, 2] . In addition to its role in Vpr induces apoptosis in many cell types; however, the mechanisms by which it induces cell death vary and are often cell-type-specific (reviewed in [6] ), with both caspase-8 and caspase-9-mediated mechanisms having been implicated [7] [8] [9] . In some nonrenal cell types, Vpr induces activation of cellular DNA damage responses leading to G2/M arrest and Bcl-2-associated X protein (Bax)-dependent apoptosis [10] [11] [12] [13] [14] ; in others, Vpr directly injures mitochondria [15] .
Mitogen-activated protein kinases (MAPKs) are important mediators of HIV-induced renal pathogenesis [15, 16] . Whereas Extracellular signal-regulated kinase (ERK) activation is classically associated with promoting cellular proliferation [17] , it can also induce cell cycle arrest and/or apoptosis, particularly in the presence of cellular stressors such as DNA damage [18, 19] . Sustained activation of ERK can induce apoptosis in neurons via a caspase-8-dependent pathway that is independent of Fas or FAS-associating death domain (FADD) [18, 19] .
Here, we report that transduction of a human RTEC line (HK2) with Vpr induced mitochondrial damage and apoptosis that was dependent upon activation of caspase-8 and caspase-9. Knock-down of BID and/or Bax expression using lentiviral shRNA vectors suppressed Vpr-induced apoptosis. We then demonstrate that Vprinduced apoptosis was associated with prolonged ERK activation, and that inhibition of ERK activation with the specific MEK inhibitor U0126 reduced Vpr-induced apoptosis, caspase-8 and caspase-9 activation, and BID cleavage to tBID. Importantly, activated ERK was detected in RTEC in HIVAN patient biopsy specimens, strongly suggesting that these findings are relevant to HIVAN pathogenesis in vivo.
Methods

Cell culture
Human embryonic kidney (HEK) 293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS), penicillin/streptomycin and L-glutamine. Adult human proximal tubule epithelial cells (HK-2) (described in [20] ) were cultured in serum-free keratinocyte media with growth supplement (GIBCO).
Generation of pseudotyped virus, transfection and infection
Lentiviral vectors were pseudotyped with vesicular stomatitis virus glycoprotein (VSV-g) and expressed vpr (VSV-HR-vpr-IRES-EGFP, abbreviated HR-Vpr), empty vector (VSV-HR-IRES-EGFP, abbreviated HR). HK2 cells were transduced according to previously published methods [2] . Lentiviral shRNA vectors included VIRHD/E/siLuc [21] (abbreviated shLuc, gift of Dr Luca Gusella, Mt. Sinai School of Medicine), shBID and shBax (OpenBiosystems, Cat# RHS4430-99157271 and Cat# RHS4430-99140545).
For mitochondrial assays using JC-1, we used VSVpseudotyped lentiviral vectors encoding hexahistidine (His) and hemagglutinin (HA)-tagged Vpr (pHR-His-HA-VPR-IRES-GFP, abbreviated pHA-Vpr) and His-HA-tagged pHA-Vpr (Q65R) (inactive mutant) in which the start codon for GFP was mutated and a premature stop codon was added to GFP using the QuickChange site directed mutagenesis kit (Stratagene). pHA-Vpr and pHA-Vpr (Q65R) were gifts of Vincente Planelles, University of Utah [22] .
Caspase and ERK inhibition
Caspase-8 and caspase-9 were inhibited using Z-IETD-FMK and Z-LEHD-FMK, respectively (R&D Systems), at 60 uM. ERK activation was inhibited by incubation with U0126 (Cell Signaling) at 10 mM.
Cell cycle analysis
Cells were collected by trypsinization, fixed in 50% ethanol, stained with propidium iodide (Invitrogen) and treated with 0.01 mg/ml percentage RNAse A (Puregement, Gentra Systems). Cell cycle parameters were measured using the FACScaliber flow cytometer equipped with CellQuest Software in the Mount Sinai Flow Cytometry Shared Research Facility and analyzed using FlowJo software version 6.4.7. Cell fragments were excluded from analysis on the forward scatter/side scatter plot. Gates from control transductions were applied to other experimental groups. Each experiment was conducted at least three separate times and representative plots are provided.
Real-time PCR
RNA was extracted using the RNeasy Mini Kit (Qiagen). cDNA was made using SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen). qPCR was performed using QuantiTect SYBR Green PCR Kit (Qiagen) at the Mount Sinai Quantitative PCR Shared Research Facility according to the protocol: 95C 15 min, 40 cycles of 94C 15 s, 58C 30 s, 72C 30 s. Primers were to Bax (sense: 5 0 -TTTGCTTCAGGGTTTCATCC, antisense: 5 0 -CAGT TGAAGTTGCCGTCAGA) with cyclophilin as a housekeeping gene (sense: 5 0 -AGGGTGGTGACTTTACAC GC, antisense: 5 0 -ATCCAGCCATTCAGTCTTGG). The threshold cycle (Ct) for cyclophilin was subtracted from the Ct for each transcript (DCt). The fold-change difference in expression for each gene was defined as 2 (DCt experiment -DCt control) . Unpaired t-tests with a twosided P value of less than 0.05 were used to compare the expression of each gene.
Western blots
Whole-cell extracts were run on a 4-20% Tris-glycine gel (Invitrogen) and transferred to PVDF membranes (Millipore). Primary antibodies were to beta actin (Santa Cruz), PARP-1, phospho-ERK1,2, total ERK1,2, BID, JNK, and phospho-JNK (Cell Signaling). Secondary antibodies were horseradish peroxidase-conjugated goat antirabbit or antimouse (Jackson ImmunoResearch), and detection was by chemiluminescence (ECL; Amersham Biosciences).
Mitochondrial assays
To assess the integrity of mitochondrial membrane polarization (MMP), cells were incubated with Mitotracker RedCMXRos (Invitrogen) for 30 min, trypsinized and analyzed by flow cytometry. MMP was also assessed by incubating cells with 5 mg/ml of JC-1 (Anaspec) prior to flow cytometric analysis of red and green fluorescence.
Caspase activation assays
Activation of Caspase 3/7, 8 and 9 was measured using Caspase Glo Assay kits (Promega). Luciferase activity was measured using a Wallac 1420 Manager Plate Read (Perkin Elmer). CaspaseGlo data are represented as the average of five experiments conducted in parallel.
Renal biopsy specimens and immunohistochemistry
Human biopsy material was collected previously from HIV-infected patients after informed consent under a protocol approved by the Mount Sinai Institutional Review Board. Kidney tissue was obtained from eight patients with HIVAN. Kidney biopsies from six HIVseronegative patients with minimal change disease (MCD) were collected at Columbia University under a protocol approved by its Institutional Review Board. Immunostaining of paraffin-embedded renal biopsy specimens for phospho-ERK1,2 was conducted as described previously [15] .
Statistical analysis
Flow cytometry data were analyzed using a chi-square test. Statistical significance was defined as P < 0.05. qPCR and caspase activation data were analyzed using the Student's t-test for populations with unequal variance and statistical significance was defined as two-sided (P < 0.05).
Results
Vpr induces apoptosis in human kidney cells
Previous studies in our lab demonstrated that Vpr induces apoptosis in human renal tubular epithelial cells (HK2) as determined by annexin V/propidium iodide staining [5] . We examined cellular DNA content by staining HK2 with propidium iodide after HR-Vpr transduction to characterize cell cycle regulation and determine the relative proportion of cells that became hypoploid (an indicator of apoptosis) compared to cells transduced with empty HR control vector. Five days after transduction, analysis of propidium-stained cells revealed that Vpr induced a marked increase in the proportion of hypodiploid cells (33.8%) compared to controltransduced cells (6.3%) ( Fig. 1a ). Furthermore, Vpr transduction led to a dramatic increase in the percentage of hyperploid (>4N) cells (32.2%) as compared to control (5.6%, P < 0.0005).
In nonrenal cell types, Vpr-induced apoptosis is accompanied by caspase activation and PARP-1 cleavage [10] . We therefore studied whether Vpr induces activation of caspase 3/7 and PARP-1 cleavage. HR-Vpr and HR control-transduced HK2 cells were assayed for caspase 3/7 activity 5 days post transduction. Caspase 3/7 activity was 60% greater at 5 days post transduction with Vpr than control ( Fig. 1b , P < 0.001). Whole cell lysates of HK2 cells were harvested 3 and 5 days after transduction with Vpr or control vector and PARP-1 cleavage was analyzed by Western blotting. Increased levels of the PARP-1 89 and 24 kD cleavage fragments were detected in HR-Vpr-transduced cells 3 days post transduction and levels increased further at 5 days, relative to HR control-transduced cells ( Fig. 1c ). Therefore, Vpr transduction of HK2 cells leads to apoptosis as measured by propidium iodide staining, caspase 3/7 activity and PARP-1 cleavage.
Vpr transduction reduces mitochondrial oxidative capacity in human kidney cells
To further characterize whether Vpr expression induces mitochondrial injury in HK2 cells, Vpr and controltransduced cells were assayed by flow cytometry 5 days post transduction after incubation with Mitotracker Red-CMXRos, a fluorescent dye whose accumulation in mitochondria is dependent upon intact MMP. Controltransduced cells displayed a single peak, indicating that cells were homogenous with respect to their content of oxidizing mitochondria ( Fig. 1d ). However, the HR-Vpr-transduced cells exhibited two peaks, one consisting of HK2 cells with less Mitotracker accumulation than control and another population with levels of Mitotracker accumulation that were similar to or higher than control ( Fig. 1d ). When the same cells were subsequently stained with propidium iodide, the percentage of hypodiploid Vpr-transduced cells was similar to the percentage of cells with reduced Mitotracker RedCMXRos staining ( Fig. 1d ), suggesting that the cells with reduced content of normal mitochondria were apoptotic. Whereas these data do not explain why some Vpr-transduced cells had increased Mitotracker RedCMXRos staining, since Vpr is known to induce cellular hypertrophy in HK2 cells [5] , it is likely that this population consists of cells with a higher number of mitochondria that have not yet undergone apoptosis.
To confirm whether reduced Mitotracker RedCMXRos staining indicated Vpr-induced loss of MMP, we transduced cells with lentiviral vectors expressing either wild-type Vpr (HA-Vpr-DGFP) or mutated Vpr [HA-Vpr(Q65R)-DGFP] which is inactive due to mutation of its DCAF1 binding site [22] . GFP was mutated in these vectors to allow use of JC-1, a mitochondrial dye which shifts from red to green fluorescence when there is loss of MMP. Flow cytometric analysis of JC-1-stained HK-2 cells 5 days after transduction revealed that HA-Vpr-DGFP induced loss of MMP in 33.3% of cells, whereas MMP was reduced in only 6% of cells transduced with HA-Vpr(Q65R)-DGFP ( Fig. 1e ).
Vpr induces caspase-8 and caspase-9 activity in human kidney cells Vpr has been shown to induce apoptosis by intrinsic and extrinsic pathways [7] . We therefore studied activation of caspase-8 and caspase-9 in Vpr-transduced HK2 cells. Five days after transduction with HR-Vpr or HR control vector, we found that caspases-8 and caspase-9 were both activated by Vpr as compared to control ( Fig. 2a and b ).
To determine whether activation of caspase-8 and 9 contributed to Vpr-induced apoptosis, the caspases were inhibited using Z-IETD-FMK and Z-LEHD-FMK, respectively. Inhibition of caspase-8 reduced apoptosis from 35 to 15.5% in HR-Vpr-transduced cells (P < 0.0001). Inhibition of caspase-9 reduced Vprinduced apoptosis from 35 to 19.2% (P < 0.0001). Coincubation with caspase-8 and caspase-9 inhibitors decreased apoptosis from 35 to 12.2% (P < 0.0001, Fig. 2c ). These results confirmed that caspase-8 and 9 activation are important in Vpr-induced apoptosis in HK2 cells; however, their effects were not additive. There was no evidence that apoptosis was preferentially prevented in hyperploid or G2/M phase cells. Caspase inhibition also reduced death in cells transduced with the HR control vector.
Bax and BID mediate Vpr-induced cell death Bax mediates Vpr-induced apoptosis in HeLa cells [11] . To investigate the role of Bax in Vpr-induced apoptosis in HK2 cells, we knocked down Bax expression using a lentiviral shRNA vector (shBax) prior to transduction with HR-Vpr or HR control vector. Transduction of HK2 cells with shBax reduced Bax mRNA expression by 89% in control-transduced cells and 83% in HR-Vprtransduced cells compared to control shRNA (shLuc) (Fig. 3a) . shBax transduction decreased the percentage of cells undergoing Vpr-induced apoptosis from 49 to 11.7% 5 days after transduction ( Fig. 3b , P < 0.0005). Compared to cells transduced with HR-Vpr and shLuc, in cells transduced with Vpr and shBax, the decrease in cell death was associated with a concomitant increase in cells in G0/ G1 (20.3 to 37.6%; P < 0.0005) and G2/M (14.3 to 30.5%; P < 0.0005). Knock-down of Bax also reduced death in control-transduced cells with concomitant small increases in each phase of the cell cycle.
In caspase-8-mediated apoptosis, caspase-8 cleaves BID to tBID and tBID subsequently promotes the proapoptotic activity of Bax. We therefore studied whether Vpr induces BID cleavage in HK2 cells. Whole cell extracts from Vpr and control-transduced cells were collected 3 and 5 days post transduction and analyzed by Western blotting using anti-BID antibody. tBID became detectable at 3 days and levels increased at 5 days post transduction with Vpr ( Fig. 3c ).
To determine whether BID is necessary for Vpr-induced apoptosis, BID expression was knocked down using lentiviral shRNA (shBID). Transduction of HK2 cells with shBID reduced BID protein levels (Fig. 3d ). HK2 cells were transduced with shBID 2 days before transduction with HR-Vpr. Five days after transduction with HR-Vpr cells were stained with propidium iodide and analyzed by flow cytometry. shBID decreased the percentage of cells that became hypoploid after Vpr transduction from 35.2 to 9.8% (P < 0.0005). This decrease in cell death was associated with a corresponding increase in hyperploid cells from 16.6 to 34% ( Fig. 3e ; P < 0.0005) compared to cells transduced with shLuc control shRNA vector. Together, these experiments implicate BID in Vpr-induced cell death in HK2 cells.
To determine whether the effects of BID and Bax are additive, we simultaneously transduced HK2 cells with shBID and shBax 3 days before transduction with HR-Vpr and analyzed propidium iodide-stained cells 5 days later. Co-transduction with shBID and shBax reduced the Vpr-induced hypodiploid fraction from 21.3 to 6.7% (P < 0.0005), and increased the hyperploid fraction from 14.4 to 27.6% ( Fig. 3f ; P < 0.0005). Transduction of HK2 cells with shBID, shBax, or both vectors suppressed Vprinduced cell death to levels one-third those of HR-Vpr with shLuc control (Fig. 3g ). There was no evidence that the effects of shBID and shBax on cell death were additive.
Caspase 8 activation by Vpr is due to prolonged ERK activation
Mitogen-activated protein kinase pathways have been implicated as mediators of HIV renal pathogenesis [15] Vpr-induced apoptosis in HIVAN Snyder et al. 1111 and prolonged ERK activation can induce caspase-8dependent apoptosis [18] . JNK has a role in Vpr-induced apoptosis in monocytic cells [16] . We therefore studied whether Vpr induces activation of JNK and/or ERK in HK2 cells. Western blotting of total cell lysate collected after transduction with HR-Vpr and HR-control revealed no evidence of JNK activation (Fig. 4a) , but there was a striking increase in ERK phosphorylation 1 and 5 days after Vpr transduction relative to control (Fig. 4b) .
To determine whether ERK activation was necessary for activation of caspase-8, MEK1 and MEK2 (activators of ERK) were inhibited using the specific inhibitor U0126.
Inhibition of ERK phosphorylation was confirmed by
Vpr-induced apoptosis in HIVAN Snyder et al. 1113 Fig. 3 . shRNA to Bax or BID decreases Vpr-induced cell death in a nonadditive manner. (a) Transduction with shBax 2 days prior to HR or HR-Vpr reduced Bax RNA levels by 89% in HR-transduced cells and by 83% in HR-Vpr-transduced cells compared to co-transduction with shLuc ( Ã P < 0.0001). (b) shBax decreased cell death from 49 to 11.7% of HR-Vpr-transduced cells at 5 dpi, with a corresponding increase in the percentage of G 0 /G 1 and G2/M cells. Ã P < 0.0005 decrease in hypoploidy in (iv) compared to (iii). (c) tBID was detected 3 and 5 dpi following HR-Vpr-transduction of HK2 cells. (d) Transduction of HK2 cells with shBID reduced total BID protein levels compared to shLuc control at 5dpi. (e) Transduction with shBID 2 days prior to HR or HR-Vpr decreased Vpr-induced cell death from 35.3 to 9.8% of cells with a corresponding increase in the hyperploid population from 16.6 to 34.0%. Ã P < 0.0005 for change in hypoploid and hyperploid populations in (iii) compared to (i) and for (iv) compared to (iii). (f) Transduction of HK2 cells with shBID and shBax 2 days prior to transduction with HR-Vpr reduced the percentage of hypodiploid cells from 21.3 to 6.7% (P < 0.0005) with a corresponding increase in the hyperdiploid population from 14.4 to 27.6% (P < 0.0005). (g) Inhibition of Bax, BID, or both reduced the hypodiploid fraction to approximately one-third of levels induced by transduction with HR-Vpr and shLuc ( Ã P < 0.0005). , and decreased cell death. The effects of U0126 were more pronounced with incubation for 5 days (vi) than for 2 days (v). Ã P < 0.0005 for changes in hypodiploid, G2/M and hyperploid fractions in (iv) compared to (i) and (v) and (vi) compared to (iv). Incubation of HK2 cells with the MEK1,2 inhibitor U0126 reduced caspase-8 activation (e) and caspase-9 activation (f) following HR-Vpr transduction to levels similar to those found in cells transduced with the HR control vector ( Ã P < 0.0001).
Western blotting of protein lysate from HR-Vpr and HR-control transduced cells after treatment with U0126 ( Fig. 4c) . Incubation with U0126 for the third and fourth days or all 5 days after transduction with Vpr inhibited cleavage of BID to tBID (Fig. 4c ). These data demonstrate that prolonged inhibition of ERK activation diminished BID cleavage in Vpr-transduced cells.
We then studied whether treating Vpr-transduced HK2 cells with U0126 could prevent Vpr-induced apoptosis. Cells were transduced with HR-Vpr and subsequently incubated with U0126 for either all 5 days prior to analysis or for the final 2 days prior to analysis. Flow cytometric analysis of propidium iodide-stained cells revealed that MEK inhibition with U0126 for the final 2 days prior to analysis reduced the hypoploid fraction in Vpr-transduced cells from 28.1 to 22.1% ( Fig. 4c ; P < 0.0005). Incubation of U0126 for all 5 days after HR-Vpr transduction further decreased accumulation of hypodiploid cells to 16.1% ( Fig. 4d ; P < 0.0005). MEK inhibition with U0126 also had pronounced effects upon cell cycle dynamics in Vpr-transduced cells. Incubation with U0126 for the final 2 days prior to analysis eliminated the greater than 8N peak [ Fig. 4d (v)] and incubation with U0126 for all 5 days following Vpr transduction decreased the percentage of hyperploid cells from 38.2 to 12.8% [ Fig. 4d(vi) ; P < 0.0005] and induced a shift of hyperploid cells to the G2/M peak. Interestingly, MEK inhibition with U0126 had no effect upon the percentage of G0/G1 cells, suggesting that U0126 did not exert its effects by preventing cells from transitioning from G0/G1 to S phase but prevented Vpr-transduced cells from progressing from G2 through mitosis.
Since we had found that MEK inhibition with U0126 decreased Vpr-induced cell death, we studied the effect of U0126 upon caspase-8 and caspase-9 activation 5 days after transduction with Vpr. Incubation with U0126 reduced Vpr-induced activation of caspases-8 and 9 to levels found in control-transduced cells ( Fig. 4e and f ; P < 0.0001). These results demonstrate that ERK activation is required for Vpr-induced caspase-dependent apoptosis in HK2 cells.
ERK is activated in RTEC in patients with HIVAN
To determine whether ERK is activated in RTEC in HIVAN specimens in vivo, we performed immunohistochemistry to detect phospho-ERK in HIVAN biopsy samples and biopsy samples from patients with minimal change disease (MCD), a form of proteinuric renal disease in which, in contrast to HIVAN, patients rarely develop tubulointerstitial injury or progressive renal failure. We detected phospho-ERK in the RTEC in HIVAN biopsies but not MCD (Fig. 5a ). These results confirm that the 1116 AIDS 2010, Vol 24 No 8 ERK activation that we observed in Vpr-transduced HK2 cells in vitro recapitulates findings in patients with HIVAN in vivo.
Discussion
In developed countries, widespread availability of antiretroviral therapy has led to dramatic reductions in morbidity and mortality due to opportunistic infections. Renal disease has become the fourth leading diagnosis contributing to death among Americans with HIV/AIDS [23] and HIVAN is the leading cause of ESRD in HIVseropositive patients [24] . The mechanisms by which expression of viral genes in RTEC leads to tubulointerstitial disease, characterized by dysregulated RTEC apoptosis and proliferation, remain poorly characterized. Previous studies have described HIV-1 Vpr as a principal HIV gene responsible for inducing RTEC hypertrophy and apoptosis [5] . Here, we define the mechanisms of Vpr-induced apoptosis in human RTEC.
Vpr can induce apoptosis in many cells types but the mechanisms by which it does so differ depending upon cell type and context [6] . Most previous research has focused upon the ability of Vpr to injure mitochondria either by direct binding to the adenine nucleotide transporter on the outer mitochondrial membrane, or via up-regulation of Bax with resultant loss of mitochondrial membrane polarization and release of proapoptotic factors, culminating in caspase-9 activation and apoptosis [25, 26] .
When we found that Vpr induced apoptosis in RTEC, we initially hypothesized that the mechanism of apoptosis in these cells was via Bax-dependent mitochondrial injury, leading to activation of caspase-9 as reported in HeLa cells by Andersen et al. [11] . As we predicted, Vpr induced caspase-9 activation and we also found that Bax expression was important for Vpr-induced apoptosis. To our surprise, however, we also found that Vpr activated caspase-8 and that inhibition of caspase-8 was as effective in preventing cell death as caspase-9 inhibition. Moreover, caspase-9 inhibition did not reduce cell death more than caspase-8 inhibition alone, suggesting that caspase-9 might be acting downstream of caspase-8. Whereas our data demonstrating a role for caspase-8 in Vpr-induced apoptosis were unexpected, Vpr has been reported to induce caspase-8-mediated apoptosis in human neurons and CD8 cells [27, 28] .
Since active caspase-8 can cleave BID to tBID, which can then facilitate Bax-induced mitochondrial injury, we tested whether suppression of BID expression could prevent Vpr-induced apoptosis. Transduction of HK2 cells with shRNA directed against BID prevented apoptosis as effectively as Bax shRNA, and co-suppres-sion of Bax and BID did not further reduce apoptosis, suggesting that BID is upstream of Bax-induced apoptosis in Vpr-transduced HK2 cells. Activation of caspase-8 is classically associated with receptor-mediated (extrinsic) apoptosis [29, 30] . In preliminary studies, we were unable to inhibit Vpr-induced apoptosis using blocking antibodies directed against Fas, the TNF-a receptor, or the TRAIL receptor (data not shown). Conaldi et al. [31] also reported that HIV-1-induced apoptosis in human RTEC is not prevented by Fas blocking antibodies.
Previous studies have described the role of the HIV-1 Nef protein in ERK activation in podocytes. This study is the first to focus on ERK activation in RTEC in HIVAN and is also the first to demonstrate a role for Vpr-induced activation of ERK as a stimulus for apoptosis. Whereas other studies have reported a role for JNK activation in Vpr-induced apoptosis in nonrenal cell types [16] , we found no evidence of JNK activation in Vpr-transduced HK2 cells. As expression of HIV-1 Nef can also activate ERK signaling in podocytes, the combined effects of Nef and Vpr on ERK signaling in RTEC require future study.
Our studies demonstrate that ERK activation is necessary for caspase-8 activation in Vpr-transduced RTEC and that inhibition of ERK kinases MEK1 and MEK2 with the highly specific inhibitor U0126 decreases caspase-8 activation and cleavage of BID to tBID. We therefore propose a model in which prolonged ERK activation results in caspase-8 activation, leading to cleavage of BID to tBID, which facilitates Bax-induced mitochondrial permeablization, caspase-9 activation, and cell death. This model is depicted in Fig. 5b , and is similar to the pathway described for neuronal apoptosis in response to oxidative stress [32] and in HEK 293 cells subjected to prolonged ERK activation [18] . The mechanism by which Vpr induces ERK activation in RTEC is unknown.
Though ERK activation is commonly associated with promotion of cellular proliferation, ERK signaling can also induce cell cycle arrest in several cell types [33, 34] . Furthermore, prolonged ERK activation facilitates glutamate and oxidative stress-induced toxicity in neuronal cell lines and primary culture [19] , and apoptosis in 293T cells [18] . ERK has also been implicated in vivo in a neuronal ischemic injury model [35] . Importantly, ERK activation occurs in response to various DNA damage stimuli [36] , and mediates cell-cycle arrest and apoptosis after certain forms of DNA damage, effects that were inhibited by U0126 [37] . Recent studies have demonstrated that strong ERK activation causes cell cycle arrest via phosphorylation of Cdc25A [38] . Interestingly, the phosphorylation of Cdc25A induced by ERK activation is similar to Cdc25A phosphorylation by Chk1, which occurs in response to activation of DNA damage response pathways. Since Vpr has been shown to induce ATRdependent Chk1 activation in some cell types [39] , Vpr-induced apoptosis in HIVAN Snyder et al. 1117 further research is needed to determine whether Vprinduces ATR/Chk1 dependent cell cycle arrest in human RTEC. Moreover, Vpr has been recently demonstrated to activate DNA damage response in RTEC as detected by accumulation of g-H2AX foci [40] . Since some DNA damaging agents including cisplatin, can induce ERKdependent RTEC apoptosis in vitro and in vivo [41] , future studies should further characterize Vpr-induced DNA damage response in RTEC and the mechanism by which it may lead to ERK activation.
In conclusion, these studies have identified a novel mechanism for Vpr-induced apoptosis in human RTEC. We have demonstrated that Vpr induces ERK-dependent activation of caspase-8, leading to cleavage of BID to tBID, and ultimately, caspase-9 activation and apoptosis. Moreover, ERK is activated in RTEC in biopsy samples from patients with HIVAN, a disease characterized by RTEC injury and apoptosis, but not in minimal change disease, a renal disease characterized by proteinuria without tubular injury or progressive renal failure.
